Kivexa er indiceret til antiretroviral kombinationsbehandling af Human Immunodeficiency Virus (HIV) - infektion hos voksne og unge fra 12 år.
It is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and adolescents from 12 years of age.